Prevalence of abnormal glucose metabolism in Chinese renal transplant recipients: A single centre study

Nephrology Dialysis Transplantation

Volumn 23, Issue 10, 2008, Pages 3337-3342

  Chan, Hoi Wong ^a   Cheung, Chi Yuen ^a   Liu, Yan Lun ^a   Chan, Yiu Han ^a   Wong, Ho Sing ^a   Chak, Wai Leung ^a   Choi, Koon Shing ^a   Chau, Ka Foon ^a   Li, Chun Sang ^a  

^a QUEEN ELIZABETH HOSPITAL   (Hong Kong)

Author keywords

Abnormal glucose metabolism; Renal transplant

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR RISK; CHINESE; CONTROLLED STUDY; DIABETES MELLITUS; DISORDERS OF CARBOHYDRATE METABOLISM; FEMALE; GLUCOSE TOLERANCE TEST; HUMAN; KIDNEY GRAFT; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; GLUCOSE; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM DISORDERS; GLUCOSE TOLERANCE TEST; HONG KONG; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PREDIABETIC STATE; RISK FACTORS;

EID: 52449097488     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn246     Document Type: Article

References (30)

1. Cosio FG, Pesavento TE, Kim S et al. Patient survival after renal transplantation: IV. Impact of post-transplant diabetes. Kidney Int 2002; 62: 1440-1446
2. Kasiske BL, Chakkera HA, Roel J. Explained and unexplained ischemic heart disease risk after renal transplantation. J Am Soc Nephrol 2000; 11: 1735-1743
3. Montori VM, Basu A, Erwin PJ et al. Post-transplantation diabetes: a systematic review of the literature. Diabetes Care 2002; 25: 583-592
4. Fabrizi F, Martin P, Dixit V, et al. Post-transplant diabetes mellitus and HCV seropositive status after renal transplantation: meta-analysis of clinical studies. Am J Transplant 2005; 5: 2433-2440
5. Wilkinson A, Davidson J, Dotta F et al. Guidelines for the treatment and management of new-onset diabetes after transplantation. Clin Transplant 2005; 19: 291-298
6. Davidson J, Wilkinson A, Dantal J et al. New-onset diabetes after transplantation: 2003 International consensus guidelines. Transplantation 2003; 75: SS3-SS24
7. Davidson JA, Wilkinson A. New-onset Diabetes After Transplantation 2003 International Consensus Guidelines: an endocrinologist's view. Diabetes Care 2004; 27: 805
8. Heldgaad PE, Olivarius Nde F, Hindsberger C et al. Impaired fasting glycaemia resembles impaired glucose tolerance with regard to cardiovascular risk factors: population-based, cross-sectional study of risk factors for cardiovascular disease. Diabet Med 2004; 21: 363-370
9. The DECODE-study group. European Diabetes Epidemiology Group. Is fasting glucose sufficient to define diabetes? Epidemiological data from 20 European studies. Diabetes epidemiology: Collaborative analysis of Diagnostic Criteria in Europe. Diabetologia 1999; 42(6): 647
10. Standards of medical care in diabetes-2006. Diabetes Care 2006; 29(Suppl 1): S4-S42
11. Leiter LA, Ceriello A, Davidson JA et al. Postprandial glucose regulation: new data and new implications. Clin Ther 2005; 27(Suppl 2): S42-S56
12. Tominaga M, Eguchi H, Manaka H et al. The Funagata Diabetes Study. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. Diabetes Care 1999; 22: 920-924
13. Tsang WK, Ho YW, Tong KL et al. Safety, tolerability, and pharmacokinetics of Sandimmun Neoral: conversion study in stable renal transplant recipients. Transplant Proc 1996; 28: 1330-1332
14. International Neoral Renal Transplantation Study Group. Cyclosporine microemulsion (Neoral) absorption profiling and sparse-sample predictors during the first 3 months after renal transplantation. Am J of Transplant 2002; 2: 148-158
15. Wong KM SC, Chau KF, Li CS. Abbreviated tacrolimus area-under-curve monitoring for renal transplant recipients. Am J Kidney Dis 2000; 35: 660
16. Mayer AD, Dmitrewski J, Squifflet JP et al. Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group. Transplantation 1997; 64: 436-443
17. Pirsch JD, Miller J, Deierhoi MH et al. FK506 Kidney Transplant Study Group. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. Transplantation 1997; 63: 977-983
18. Armstrong KA, Prins JB, Beller EM et al. Should glucose tolerance test be performed in all renal transplant recipients? Clin J Am Soc Nephrol 2006; 1: 100
19. Cosio FG, Pesavento TE, Osei K et al. Post-transplant diabetes mellitus: increasing incidence in renal allograft recipients transplanted in recent years. Kidney Int 2001; 59: 732-737
20. Kasiske BL, Snyder JJ, Gilbertson D et al. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 2003; 3: 178-185
21. Knoll GA, Bell RC. Tacrolimus versus cyclosporin for immunosuppression in renal transplantation: meta-analysis of randomised trials. BMJ 1999; 318: 1104-1107
22. Cheung CY, Wong KM, Chan HW et al. Paired kidney analysis of tacrolimus and cyclosporine microemulsion-based therapy in Chinese cadaveric renal transplant recipients. Transpl Int 2006; 19: 657-666
23. David-Neto E, Lemos FC, Fadel LM et al. The dynamics of glucose metabolism under calcineurin inhibitors in the first year after renal transplantation in nonobese patients. Transplantation 2007; 84: 50-55
24. Valderhaug TG, Hjelmesaeth J, Rollag H et al. Reduced incidence of new-onset post-transplantation diabetes mellitus during the last decade. Transplantation 2007; 84: 1125-1130
25. Vesco L BM, Bedrossian J, Bitker MO et al. Diabetes mellitus after renal transplantation: characteristics, outcome, and risk factors. Transplantation 1996; 61: 1475-1478
26. Knobler H, Stagnaro-Green A, Wallenstein S et al. Higher incidence of diabetes in liver transplant recipients with hepatitis C. J Clin Gastroenterol 1998; 26: 30-33
27. Fung KT, Fung J, Lai CL et al. Etiologies of chronic liver diseases in Hong Kong. Eur J Gastroenterol Hepatol 2007; 19: 659-664
28. Hirakauva EY, Ferraz ML, Perez RM et al. Prevalence of diabetes mellitus in renal transplant patients with hepatitis B or C virus infection. Transplant Proc 2002; 34: 3220-3222
29. Lao TT, Tse KY, Chan LY et al. HBsAg carrier status and the association between gestational diabetes with increased serum ferritin concentration in Chinesewomen. Diabetes Care 2003; 26: 3011-3016
30. Racusen LC, Solez K, Colvin RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713-723